Cargando…
CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis
OBJECTIVE: To deeply verify the clinical significance of CXCR3 in prediction of cancer patients’ prognosis. DATA SOURCES: We performed a meta-analysis including 12 studies searched from PubMed, Web of Science, Embase, and Cochrane databases. A total of 1,751 patients were used to analyze the associa...
Autores principales: | Zhang, Yang, Xu, Linjuan, Peng, Minggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833761/ https://www.ncbi.nlm.nih.gov/pubmed/29520155 http://dx.doi.org/10.2147/OTT.S157421 |
Ejemplares similares
-
CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors
por: Molczyk, Caitlin, et al.
Publicado: (2023) -
Systematic review and meta-analysis of the prognostic value of CXCR2 in solid tumor patients
por: Yang, Yong, et al.
Publicado: (2017) -
TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis
por: Zhang, Yang, et al.
Publicado: (2017) -
A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer
por: Zhang, Changyuan, et al.
Publicado: (2015) -
TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis
por: Wang, June, et al.
Publicado: (2017)